The two smallest modifiers on the claim carry the largest reconciliation risk.
Every single-dose vial your infusion suite opens produces two numbers Medicare now watches: what went into the patient, and what hit the sharps bin. JW and JZ are how you report both. In 2026, get them wrong and the exposure is not a denial. It is a refund calculation you never see coming.
Answer first, then the receipts
- JWJW reports the discarded amount of a separately payable drug from a single-dose vial or single-use package. The units billed are wastage, not administered drug.
- JZJZ attests there was zero discard. It is not optional filler. Since July 1, 2023 one of the two modifiers must appear on every applicable single-dose-container line.
- $Your JW units feed a federal refund. Under Section 1847A(h) of the Social Security Act, CMS calculates manufacturer refunds on discarded amounts above the applicable percentage. Mis-reported wastage distorts that number and puts your documentation in the audit path.
- ✓Clean claims come from the vial, not the coder. Vial size, dose administered, dose discarded, and reason all live in the record before anyone touches a modifier.
The numbers that define the policy
Where a wrong wastage number actually lands
This is the part most oncology billing teams miss. JW is not a local coding preference. The units you report flow upstream into a CMS refund calculation, which means an over-reported vial is not just a billing artifact, it is data in a federal reconciliation with your provider name attached.
Vial opened
A single-dose vial is drawn for one patient. Dose administered and dose discarded are fixed at this moment.
→JW / JZ applied
Administered units on the primary line; discarded units on the JW line, or JZ if none. Straight from the record.
→Refund calculation
CMS aggregates JW units per HCPCS to compute discarded amounts against the applicable percentage under SSA 1847A(h).
→Reconciliation exposure
Inflated or fabricated JW units skew the refund and flag your documentation. The record has to back every discarded unit.
80 admin / 20 JW
0 admin / 100 JW
JW and JZ, side by side
- What it says
- Drug or biological was discarded and not administered to any patient.
- Units billed
- The discarded amount only, on a separate line from the administered dose.
- Applies to
- Separately payable drugs from single-dose vials / single-use packages.
- Documentation
- Vial size, dose given, dose wasted, and the reason must be in the record.
- What it says
- There was no discarded amount. The full billed quantity was administered.
- Units billed
- None added. JZ is an attestation appended to the administered line.
- Applies to
- The same single-dose-container drugs when nothing is wasted.
- Documentation
- The record supports that the full vial reached the patient with no discard.
The four fields that keep a claim clean
CMS discarded-drug policy and the Medicare Claims Processing Manual (Chapter 17) expect wastage to be traceable to the chart. Capture these four at the chair and the modifier writes itself.
Vial size drawn
Exact single-dose vial strength opened, so administered plus wasted reconciles to the container.
Dose administered
Amount actually given to the patient, matching the treatment order and administration note.
Amount discarded
Wasted units, recorded at the time of preparation, not reconstructed later from the billed total.
Reason for waste
Why the remainder could not be used, tying to single-dose-container and USP compounding practice.
How the wastage rule got teeth
Refund provision written into law
Section 90004 of the Infrastructure Investment and Jobs Act added Section 1847A(h) of the Social Security Act, requiring manufacturer refunds for discarded amounts of certain single-dose-container drugs.
JZ created, JW made mandatory
The CY2023 Physician Fee Schedule final rule established the JZ modifier and the refund methodology, tying reported wastage directly to the calculation.
Enforcement begins
JW or JZ required on all applicable separately payable single-dose-container drugs. Claims editing follows for lines that carry neither.
Packaging and reporting reaffirmed
The CY2026 OPPS/ASC final rule carries the annually indexed per-day drug packaging threshold and keeps separately payable drug reporting, and therefore JW/JZ discipline, squarely in scope for hospital outpatient oncology.
The five mistakes we see most
JW on a multi-dose vial. The discarded-drug policy applies to single-dose containers. Multi-dose vial residual is not billable wastage.
Dropping JZ entirely. Teams append JW when there is waste but forget JZ when there is none, leaving lines with no attestation at all.
Whole-vial wastage on a dosed patient. Billing the full vial as JW when the patient received part of it fabricates discarded units.
Wastage with no chart trail. A JW line with no documented reason or amount fails the moment it is reviewed.
Treating it as a coding fix. If the four fields are not captured chairside, no downstream edit makes the modifier defensible.
Your JW units are already in a federal calculation. Make sure they are right.
ASP-RCM's oncology billing team builds the vial-to-claim workflow that keeps JW and JZ traceable to the chart, catches over-reported wastage before it bills, and holds your single-dose-container documentation to the standard a refund reconciliation demands. Fewer rejects, cleaner audits, and a wastage record that stands on its own.
Book an oncology wastage review → Talk to our teamGuidelines referenced
- CMS Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) and ASC Payment System Final Rule , separately payable drugs and per-day packaging threshold.
- CMS discarded-drug policy, JW and JZ modifiers , required on applicable single-dose-container drugs effective July 1, 2023.
- Social Security Act Section 1847A(h), added by Section 90004 of the Infrastructure Investment and Jobs Act (IIJA) , refund of discarded amounts of certain single-dose-container drugs.
- CMS Calendar Year 2023 Physician Fee Schedule Final Rule , establishment of the JZ modifier and the discarded-drug refund methodology.
- Medicare Claims Processing Manual, Chapter 17 (Drugs and Biologicals) , discarded drug and single-dose vial documentation.
- USP compounding standards , single-dose-container use and beyond-use context for wastage.
Educational summary of federal policy, not billing or legal advice. Confirm current thresholds and effective dates against the final rules and your MAC's guidance. Vial figures are illustrative.